increased sensitivity to xenobiotic induced morbidity/mortality_Blmh<tm1Geh>/Blmh<tm1Geh>

http://metadb.riken.jp/0009766EI129S1Sv129S6SvEvTac129X1SvJorI129S1Sv129X1SvJC57BL6JBlmhtm1GehBlmhtm1GehBlmhtm1Geh

increased sensitivity to xenobiotic induced morbidity/mortality_Blmh<tm1Geh>/Blmh<tm1Geh>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• bleomycin hydrolase
  http://metadb.riken.jp/db/mgi_rdf/MGI:1345186

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Blmh<tm1Geh>/Blmh<tm1Geh>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Blmh<tm1Geh>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sensitivity to xenobiotic induced morbidity/mortality
  http://purl.obolibrary.org/obo/MP_0009766

文献

http://purl.org/net/cito/citesAsAuthority

• D R. Schwartz, et.al., The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance., Proceedings of the National Academy of Sciences of the United States of America, 1999, 96
  http://rdf.ncbi.nlm.nih.gov/pubmed/10200322